Drug recalls, 2026-W16

FDA drug recalls, April 13 to 19, 2026

FDA posted 30 drug recalls the week of April 13, 2026: 30 Class II. Fresenius Kabi USA, LLC has the most, with 14.

License: openFDA publishes this file under CC0 1.0.

FDA sorts recalls by risk. Class I: using the product could cause serious health problems or death. Class II: it could cause temporary or reversible health problems. Class III: it is unlikely to cause health problems.

For pharmacies and practices

Get this every Monday

Rivvi pulls the FDA drug recalls posted in the last 7 days and sends you the list each Monday morning. Add the drugs you stock or prescribe and it flags any that match.

Watch recalls in Rivvi

Free to start. Opens Rivvi, the AI workspace for healthcare teams, with the weekly watch turned on.

Recalls posted April 13 to 19, 2026

Class II · Posted April 15, 2026 · Started March 25, 2026 · Ongoing

Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene…

Product
Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz bottles, Mfg: Geri-Care; Brooklyn, New York NDC 68788-7266-0
Firm
Preferred Pharmaceuticals, Inc., Anaheim, CA
Reason
Lack of Assurance of Sterility
Lots
Lot #: F1924R, F2024G, F2424E, G2424M, G2624P, J2424M
Quantity
720 bottles
Distribution
Nationwide within the United States
RxNorm
Not matched to RxNorm in the FDA record
Recall number
D-0443-2026

Class II · Posted April 15, 2026 · Started March 24, 2026 · Ongoing

iohexol

Product
GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1414-91.
Firm
GE Healthcare Ireland Limited, Carrigtwohill, Ireland
Reason
Presence of particulate matter
Lots
Lot# 17333197; Exp. December 10, 2028 Lot# 17333198; Exp. November 17, 2028 Lot# 17396945; Exp. December 18, 2028 Lot# 17396948; Exp. December 22, 2028 Lot# 17396953; Exp. January 11, 2029 Lot# 17396956; Exp. January 9, 2029 Lot# 17423503; Exp. January 1, 2029 Lot# 17423525; Exp. January 3, 2029 Lot# 17426429; Exp. January 1, 2029 Lot# 17426440; Exp. January 4, 2029 Lot# 17431310; Exp. January 11, 2029
Quantity
306,810 vials
Distribution
U.S. Nationwide.
RxNorm
iohexol
Recall number
D-0448-2026

Class II · Posted April 15, 2026 · Started March 24, 2026 · Ongoing

iohexol

Product
GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1413-63.
Firm
GE Healthcare Ireland Limited, Carrigtwohill, Ireland
Reason
Presence of particulate matter
Lots
Lot# 17225029; Exp. September 3, 2028 Lot# 17265376; Exp. October 3, 2028 Lot# 17270885; Exp. September 10, 2028 Lot# 17292246; Exp. October 4, 2028 Lot# 17301805; Exp. October 18, 2028 Lot# 17301807; Exp. September 7, 2028 Lot# 17301810; Exp. October 20, 2028 Lot# 17304992; Exp. October 5, 2028 Lot# 17304993; Exp. October 19, 2028 Lot# 17304996; Exp. November 25, 2028 Lot# 17321225; Exp. September 8, 2028 Lot# 17333589; Exp. November 24, 2028 Lot# 17333611; Exp. November 26. 2028 Lot# 17333613; Exp. November 23. 2028 Lot# 17357000; Exp. December 5, 2028 Lot# 17366399; Exp. December 14, 2028…
Quantity
866,570 vials
Distribution
U.S. Nationwide.
RxNorm
iohexol
Recall number
D-0447-2026

Class II · Posted April 15, 2026 · Started March 20, 2026 · Ongoing

Vancomycin HCL

Product
Vancomycin HCL, 1 gram added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5082-01
Firm
Fagron Compounding Services, Wichita, KS
Reason
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
Lots
Lot: C274-000050987, Exp.:7/12/2026; C274-000049425, Exp.: 5/2/2026; C274-000050069, Exp.: 5/30/2026; C274-000050346, Exp.: 6/10/2026; C274-000050698, Exp.: 6/27/2026; C274-000050699, Exp.:6/27/2026; C274-000050775, Exp.:7/4/2026.
Quantity
11,680 bags
Distribution
Nationwide in the U.S.A.
RxNorm
Not matched to RxNorm in the FDA record
Recall number
D-0442-2026

Class II · Posted April 15, 2026 · Started March 20, 2026 · Ongoing

Vancomycin HCI

Product
Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5085-01
Firm
Fagron Compounding Services, Wichita, KS
Reason
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
Lots
Lot: C274-000050858, Exp.:7/6/2026; C274-000051018, Exp.: 7/13/2026; C274-000049194, Exp.: 4/20/2026; C274-000049591, Exp.: 5/9/2026; C274-000049592, Exp.: 5/9/2026; C274-000049823, Exp.: 5/18/2026; C274-000050301, Exp.: 6/8/2026; C274-000050411, Exp.: 6/13/2026; C274-000051056, Exp.:7/18/2026.
Quantity
16,130 bags
Distribution
Nationwide in the U.S.A.
RxNorm
Not matched to RxNorm in the FDA record
Recall number
D-0441-2026

Class II · Posted April 15, 2026 · Started March 20, 2026 · Ongoing

Vancomycin HCI

Product
Vancomycin HCI, 1.25 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5083-01
Firm
Fagron Compounding Services, Wichita, KS
Reason
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
Lots
Lot: C274-000050857, Exp.:7/6/2026; C274-000049316, Exp.: 4/26/2026; C274-000049367, Exp.: 4/28/2026; C274-000049496, Exp.: 5/3/2026; C274-000049518, Exp.: 5/4/2026; C274-000049535, Exp.: 5/5/2026; C274-000049653, Exp.: 5/11/2026; C274-000049654, Exp.: 5/11/2026; C274-000049745, Exp.: 5/16/2026; C274-000050128, Exp.: 5/31/2026; C274-000050151, Exp.: 6/1/2026; C274-000050184, Exp.: 6/6/2026; C274-000050504, Exp.: 6/15/2026; C274-000050662, Exp.: 6/21/2026; C274-000050836, Exp.: 7/5/2026; C274-000051014, Exp.: 7/13/2026; C274-000051057, Exp.: 7/18/2026; C274-000051240, Exp.: 7/25/2026.
Quantity
34,260 bags
Distribution
Nationwide in the U.S.A.
RxNorm
Not matched to RxNorm in the FDA record
Recall number
D-0440-2026

Class II · Posted April 15, 2026 · Started March 20, 2026 · Ongoing

norepinephrine Bitartrate

Product
norepinephrine Bitartrate, 32mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5027-02
Firm
Fagron Compounding Services, Wichita, KS
Reason
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
Lots
Lot: C274-000050004, Exp.: 4/24/2026; C274-000050295, Exp.:5/8/2026; C274-000050773, Exp.: 6/4/2026; C274-000051219, Exp.: 6/21/2026; C274-000051318, Exp.: 6/27/2026; C274-000051602, Exp.: 7/12/2026.
Quantity
5140 bags
Distribution
Nationwide in the U.S.A.
RxNorm
Not matched to RxNorm in the FDA record
Recall number
D-0439-2026

Class II · Posted April 15, 2026 · Started March 20, 2026 · Ongoing

norepinephrine Bitartrate,16mg per 250mL 0.9% Sodium Chloride Injection USP

Product
norepinephrine Bitartrate,16mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5026-02
Firm
Fagron Compounding Services, Wichita, KS
Reason
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
Lots
Lot: C274-000049934, Exp.: 4/23/2026; C274-000049963, Exp.:4/24/2026; C274-000050074, Exp.: 4/30/2026; C274-000050123, Exp.:5/1/2026; C274-000050296, Exp.: 5/9/2026; C274-000050420, Exp.: 5/16/2026; C274-000050774, Exp.:6/5/2026; C274-000050924, 6/7/2026; C274-000050961, Exp.: 6/11/2026; C274-000050991, Exp.: 6/12/2026; C274-000051139, Exp.:6/19/2026; C274-000051166, Exp.:6/20/2026; C274-000051198, Exp.:6/21/2026; C274-000051343, Exp.:6/28/2026.
Quantity
25,260 bags
Distribution
Nationwide in the U.S.A.
RxNorm
Not matched to RxNorm in the FDA record
Recall number
D-0438-2026

Class II · Posted April 15, 2026 · Started March 19, 2026 · Ongoing

clonidine

Product
Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ, NDC 0591-3510-04 carton, NDC 0591-3510-54 pouch
Firm
Teva Pharmaceuticals USA, Inc, Parsippany, NJ
Reason
CGMP Deviations: use of an unapproved raw material
Lots
Lot: 100053892, Exp.: 04/2026; 100057899, Exp.: 05/2026; 100062704, Exp.: 02/2027.
Quantity
113,943 Cartons
Distribution
Within U.S
RxNorm
clonidine (RxCUI 998671, 998675, 998679)
Recall number
D-0474-2026

Class II · Posted April 15, 2026 · Started March 19, 2026 · Ongoing

clonidine

Product
Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ, NDC 0591-3509-04 carton, NDC 0591-3509-54 pouch
Firm
Teva Pharmaceuticals USA, Inc, Parsippany, NJ
Reason
CGMP Deviations: use of an unapproved raw material
Lots
Lot: 100060002, Exp.: 07/2026; 100066802, Exp.: 05/2027
Quantity
62,136 Cartons
Distribution
Within U.S
RxNorm
clonidine (RxCUI 998671, 998675, 998679)
Recall number
D-0473-2026

Class II · Posted April 15, 2026 · Started March 19, 2026 · Ongoing

clonidine

Product
Clonidine Transdermal System, USP, 0.1 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx Only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ, NDC 0591-3508-04 carton, NDC 0591-3508-54 pouch
Firm
Teva Pharmaceuticals USA, Inc, Parsippany, NJ
Reason
CGMP Deviations: use of an unapproved raw material
Lots
Lot: 100060315, Exp.: 04/2026; 100068644, Exp.: 01/2027.
Quantity
124,054 Cartons
Distribution
Within U.S
RxNorm
clonidine (RxCUI 998671, 998675, 998679)
Recall number
D-0472-2026

Class II · Posted April 15, 2026 · Started March 17, 2026 · Ongoing

Xanax XR

Product
Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLC, Morgantown, WV 06506, U.S.A, Made in Ireland, NDC 58151-506-91
Firm
Viatris, Inc., Canonsburg, PA
Reason
Failed Dissolution Specifications
Lots
Lot# 8177156, Exp Date: 02/28/2027
Distribution
US Nationwide.
RxNorm
Not matched to RxNorm in the FDA record
Recall number
D-0444-2026

Class II · Posted April 15, 2026 · Started March 13, 2026 · Ongoing

lanreotide acetate

Product
Lanreotide Injection, 120 mg/0.5 mL, Box contains 1 Pre-filled syringe, Single dose only, Rx Only, Manufactured by: Pharmathen International, S.A., Rodopi, Greece. Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC 69097-906-67
Firm
Cipla USA, Inc., Warren, NJ
Reason
Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.
Lots
Lot, expiry: 4401699IR1, Exp. 5/31/2026; 4401699IR2, Exp. 5/31/2026; 4401700IR1, Exp. 5/31/2026; 4401701IR1, Exp. 5/31/2026; 4401702IR1, Exp. 5/31/2026; 4401722IR1, Exp. 5/31/2026; 4401723IR1, Exp. 5/31/2026; 4401724IR1, Exp. 5/31/2026; 4401725IR1, Exp. 5/31/2026; 4401732IR1, Exp. 5/31/2026; 4401768IR1, Exp. 6/30/2026 4401769IR1, Exp. 11/30/2026; 4401787IR1, Exp. 11/30/2026; 4401815IR1, Exp. 11/30/2026; 4401816IR1, Exp. 11/30/2026; 4401834IR1, Exp. 11/30/2026; 4401835IR1, Exp. 11/30/2026; 4401846IR1, Exp. 11/30/2026; 4401851IR1, Exp. 11/30/2026; 4500017IR1, Exp. 12/31/2026; 4500031IR1, Exp…
Distribution
Nationwide in the USA
RxNorm
lanreotide acetate (RxCUI 749811, 749814, 749817)
Recall number
D-0423-2026

Class II · Posted April 15, 2026 · Started March 13, 2026 · Ongoing

lanreotide acetate

Product
Lanreotide Injection, 120 mg*/0.5 mL, Box contains 1 Pre-filled syringe and 1 safety needle, Single dose only, Rx Only, Manufactured by: Pharmathen International, S.A., Rodopi, Greece. Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-870-67
Firm
Cipla USA, Inc., Warren, NJ
Reason
Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.
Lots
Lot, expiry: 4401666IR1, Exp 8/31/2027; 4401703IR1, Exp 9/30/2027; 4401703IR2, EXP 9/30/2027; 4401704IR1, Exp 9/30/2027; 4401705IR1, Exp 9/30/2027; 4401706IR1, Exp 9/30/2027; 4401720IR1, Exp 9/30/2027; 4401721IR1, Exp 9/30/2027; 4401733IR1, Exp 9/30/2027; 4401770IR1, Exp 9/30/2027; 4401777IR1, Exp 9/30/2027; 4401788IR1, Exp 10/31/2027; 4401804IR1, Exp 10/31/2027; 4401805IR1, Exp 10/31/2027; 4401824IR1, Exp 10/31/2027; 4401860IR1, Exp 10/31/2027; 4500019IR1, Exp 11/30/2027; 4500035IR1, Exp 11/30/2027; 4500036IR1, Exp 11/30/2027; 4500078IR1, Exp 11/30/2027; 4500079IR1, Exp 11/30/2027…
Quantity
54,583 syringes
Distribution
Nationwide in the USA
RxNorm
lanreotide acetate (RxCUI 749811, 749814, 749817)
Recall number
D-0422-2026

Class II · Posted April 15, 2026 · Started March 11, 2026 · Ongoing

dextrose monohydrate

Product
5% Dextrose Injection, USP 12.5 g per 250 mL (50 mg per mL) 250 mL in a 250 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-458-05, Unit of Sale NDC Number: 65219-458-30.
Firm
Fresenius Kabi USA, LLC, Lake Zurich, IL
Reason
Lack of Assurance of Sterility
Lots
Batch# 6402165, Exp Date: 05/30/2028.
Distribution
US Nationwide , Alaska, and Puerto Rico.
RxNorm
dextrose monohydrate (RxCUI 1795607, 1795609, 1795610, 1795612, 1795616)
Recall number
D-0437-2026

Class II · Posted April 15, 2026 · Started March 11, 2026 · Ongoing

dextrose monohydrate

Product
5% Dextrose Injection, USP 5 g per 100 mL (50 mg per mL) 100 mL in a 100 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-464-05, Unit of Sale NDC Number: 65219-464-50.
Firm
Fresenius Kabi USA, LLC, Lake Zurich, IL
Reason
Lack of Assurance of Sterility
Lots
Batch# 6402399, 6402400, 6402401, Exp Date: 02/28/2027.
Distribution
US Nationwide , Alaska, and Puerto Rico.
RxNorm
dextrose monohydrate (RxCUI 1795607, 1795609, 1795610, 1795612, 1795616)
Recall number
D-0436-2026

Class II · Posted April 15, 2026 · Started March 11, 2026 · Ongoing

dextrose monohydrate

Product
5% Dextrose Injection, USP 2.5 g per 50 mL (50 mg per mL) 50 mL in a 100 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-456-05, Unit of Sale NDC Number: 65219-456-60.
Firm
Fresenius Kabi USA, LLC, Lake Zurich, IL
Reason
Lack of Assurance of Sterility
Lots
Batch# 6402296, Exp Date: 07/31/2026.
Distribution
US Nationwide , Alaska, and Puerto Rico.
RxNorm
dextrose monohydrate (RxCUI 1795607, 1795609, 1795610, 1795612, 1795616)
Recall number
D-0435-2026

Class II · Posted April 15, 2026 · Started March 11, 2026 · Ongoing

sodium chloride

Product
0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL), 1,000 mL in a Single Dose freeflex bag, Rx only, BD Becton, Dickson and Company, 1 Becton Drive, Franklin Lakes, NJ 07417, Distributed by BD, Manufactured by Fresenius Kabi, Unit of Sale NDC Number: 17271-701-07.
Firm
Fresenius Kabi USA, LLC, Lake Zurich, IL
Reason
Lack of Assurance of Sterility
Lots
Batch# 24EU10010, Exp Date: 05/31/2027.
Distribution
US Nationwide , Alaska, and Puerto Rico.
RxNorm
sodium chloride (RxCUI 1807631, 1807632, 1807633, 1807634, 1807639)
Recall number
D-0434-2026

Class II · Posted April 15, 2026 · Started March 11, 2026 · Ongoing

sodium chloride

Product
0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 1,000 mL in a Single Dose freeflex bag, 1,000 mLx10, Fresenius Medical Care, Waltham, MA 02451, Distributed by: Fresenius Medical Care RTG, LLC, Manufactured by: Fresenius Kabi, Unit of Use NDC: 65219-282-01, Unit of Sale NDC Number: 65219-282-10.
Firm
Fresenius Kabi USA, LLC, Lake Zurich, IL
Reason
Lack of Assurance of Sterility
Lots
Batch# 23SU10001, Exp Date: 12/31/2026; Batch# 24AU10003, 24AU10004, 24AU10005, 24AU10008, Exp Date: 01/31/2027; Batch # 24EU10001, 24EU10002, Exp Date: 05/31/2027; Batch# 24PU10002, Exp Date: 11/30/2027; Batch# 25BU10003, Exp Date: 02/29/2028; Batch# 25EU10005, Exp Date: 05/31/2028.
Distribution
US Nationwide , Alaska, and Puerto Rico.
RxNorm
sodium chloride (RxCUI 1807639)
Recall number
D-0433-2026

Class II · Posted April 15, 2026 · Started March 11, 2026 · Ongoing

sodium chloride

Product
0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL) 500 mL in a Single Dose freeflex bag, 500 mL x 20, Manufactured for: Fresenius Kabi USA, LLC ("Fresenius Kabi"), IL 60047, Unit of Use NDC: 65219-432-20, Unit of Sale NDC Number: 65219-432-85.
Firm
Fresenius Kabi USA, LLC, Lake Zurich, IL
Reason
Lack of Assurance of Sterility
Lots
Batch# 23DU10004, Exp Date: 04/30/2026; Batch# 23HU10006, Exp Date: 06/30/2026.
Distribution
US Nationwide , Alaska, and Puerto Rico.
RxNorm
sodium chloride (RxCUI 1807634, 1807639)
Recall number
D-0432-2026

Class II · Posted April 15, 2026 · Started March 11, 2026 · Ongoing

sodium chloride

Product
0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 250 mL in a Single Dose freeflex bag, Rx only, BD Becton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417, Distributed by BD, Manufactured by: Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Sale NDC Number: 17271-701-05.
Firm
Fresenius Kabi USA, LLC, Lake Zurich, IL
Reason
Lack of Assurance of Sterility
Lots
Batch# 6402290, 6402291, Exp Date: 01/31/2028; Batch# 6402411, Exp Date: 02/29/2028; Batch# 6402412, 6402419, 6402424, 6402425, 6402426, 6402427, Exp Date: 03/31/2028; Batch# 6402479, 6402480, 6402517, 6402571, Exp Date: 05/31/2028; Batch# 6402518, Exp Date: 06/30/2028.
Distribution
US Nationwide , Alaska, and Puerto Rico.
RxNorm
sodium chloride (RxCUI 1807631, 1807632, 1807633, 1807634, 1807639)
Recall number
D-0431-2026

Class II · Posted April 15, 2026 · Started March 11, 2026 · Ongoing

sodium chloride

Product
0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 100 mL in a Single Dose freeflex bag, Rx only, BD Beckton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417 USA, Distributed by BD, Manufactured by: Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Sale NDC Number: 17271-701-03.
Firm
Fresenius Kabi USA, LLC, Lake Zurich, IL
Reason
Lack of Assurance of Sterility
Lots
Batch# 6402153, Exp Date: 11/30/2026; Batch# 6402297, 6402298, Exp Date: 01/31/2027; Batch# 6402377, 6402378, 6402379, Exp Date: 02/28/2027; Batch # 6402429, 6402430, 6402431, 6402432, 6402433, Exp Date: 03/31/2027; Batch# 6402434, Exp Date: 04/30/2027; Batch# 6402512, Exp Date: 05/2027; Batch# 6402574, 6402576, Exp Date: 06/30/2027.
Distribution
US Nationwide , Alaska, and Puerto Rico.
RxNorm
sodium chloride (RxCUI 1807631, 1807632, 1807633, 1807634, 1807639)
Recall number
D-0430-2026

Class II · Posted April 15, 2026 · Started March 11, 2026 · Ongoing

sodium chloride

Product
0.9% Sodium Chloride Injection, USP, 50 mL x60, Becton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417 USA, Distributed by BD, Manufactured by Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Sale NDC Number: 17271-701-02.
Firm
Fresenius Kabi USA, LLC, Lake Zurich, IL
Reason
Lack of Assurance of Sterility
Lots
Batch# 6402428, Exp Date: 10/31/2026; Batch# 6402481, 6402482, Exp Date: 11/30/2026.
Distribution
US Nationwide , Alaska, and Puerto Rico.
RxNorm
sodium chloride (RxCUI 1807631, 1807632, 1807633, 1807634, 1807639)
Recall number
D-0429-2026

Class II · Posted April 15, 2026 · Started March 11, 2026 · Ongoing

sodium chloride

Product
0.9% Sodium Chloride Injection, USP, (4,500 mg per 500 mL) (9 mg per mL) 500 mL in a 500 mL freeflex bag, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 60047, Unit of Use NDC: 65219-472-05, Unit of Sale NDC Number: 65219-472-20.
Firm
Fresenius Kabi USA, LLC, Lake Zurich, IL
Reason
Lack of Assurance of Sterility
Lots
Batch# 24LU10013, 24LU10014, Exp Date: 09/30/2027; Batch# 24NU10001, 24NU10002, Exp Date: 10/31/2027.
Distribution
US Nationwide , Alaska, and Puerto Rico.
RxNorm
sodium chloride (RxCUI 1807631, 1807632, 1807633, 1807634, 1807639)
Recall number
D-0428-2026

Class II · Posted April 15, 2026 · Started March 11, 2026 · Ongoing

sodium chloride

Product
0.9% Sodium Chloride Injection, USP, (2,250 mg per 250 mL) (9 mg per mL) 250 mL in a 250 mL freeflex bag, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 60047, Unit of Use NDC: 65219-470-05, Unit of Sale NDC Number: 65219-470-30.
Firm
Fresenius Kabi USA, LLC, Lake Zurich, IL
Reason
Lack of Assurance of Sterility
Lots
Batch# 23SU10008, Exp Date: 12/31/2026; Batch# 24JU10003, Exp Date: 07/31/2027; Batch# 24LU10011, 24LU10012, Exp Date: 9/30/2027; Batch# 6402273, 6402275, Exp Date: 01/31/2028; Batch# 6402420, 6402421, 6402422, 6402423, Exp Date: 03/31/2028; Batch# 6402473, 6402474, 6402475, 6402476, 6402485, Exp Date: 04/30/2028; Batch# 6402516, Exp Date: 05/31/2028.
Distribution
US Nationwide , Alaska, and Puerto Rico.
RxNorm
sodium chloride (RxCUI 1807631, 1807632, 1807633, 1807634, 1807639)
Recall number
D-0427-2026

Source: openFDA drug enforcement reports, as of October 14, 2026. Publisher page

About this data

Each row is one FDA drug enforcement report: one product from one firm. A week here is Monday to Sunday, keyed on the date FDA listed the recall in its weekly Enforcement Report. The date the firm started the recall is shown on each row and is often weeks earlier.

Class I means use of the product could cause serious health problems or death. Class II means it could cause temporary or reversible health problems. Class III means it is unlikely to cause health problems. RxNorm names and RxCUIs come from openFDA's match of the product to its drug label. Compounded products often have no match.

This page lists public records. It is not medical advice. Check the FDA record before acting on a recall.

Source: openFDA drug enforcement reports, as of October 14, 2026. Publisher page

Try it on your own data today.

Free to start. Most teams are using it the same day.